このアイテムのアクセス数: 0

このアイテムのファイル:
このアイテムは一定期間後に公開されます。
公開日については,アイテム画面の「著作権等」でご確認ください。
タイトル: cT1腎細胞癌に対する腹腔鏡下/ロボット支援腎部分切除術後にpT3aにUpstageした症例の予後因子
その他のタイトル: Prognostic Factors for Recurrence in Patients with cT1 Renal Cell Carcinoma Upstaging to pT3a after Laparoscopic/Robot-Assisted Partial Nephrectomy
著者: 神戸, 貴成  KAKEN_name
山﨑, 俊成  KAKEN_name
名越, 晶彦  KAKEN_name
藤原, 佑  KAKEN_name
峯, 佑太  KAKEN_name
萩本, 裕樹  KAKEN_name
服部, 悠斗  KAKEN_name
阿部, 陽平  KAKEN_name
山下, 大祐  KAKEN_name
堤, 尚史  KAKEN_name
川喜田, 睦司  KAKEN_name
著者名の別形: KAMBE, Takanari
YAMASAKI, Toshinari
NAGOSHI, Akihiko
FUJIWARA, Tasuku
MINE, Yuta
HAGIMOTO, Hiroki
HATTORI, Yuto
ABE, Yohei
YAMASHITA, Daisuke
TSUTSUMI, Naofumi
KAWAKITA, Mutsushi
キーワード: Renal cell carcinoma
cT1
pT3a
Laparoscopic/Robot-assisted partial nephrectomy
Pathological upstage
発行日: 31-Jul-2024
出版者: 泌尿器科学術研究会
誌名: 泌尿器科紀要
巻: 70
号: 7
開始ページ: 193
終了ページ: 200
抄録: Upstaging to pT3a is rare after partial nephrectomy for cT1 renal cell carcinoma (RCC), and its prognosis is reported to be poor. Of 389 patients with cT1 RCC who underwent laparoscopic/robotic assisted partial nephrectomy between 2011-2022, 27 were diagnosed with pT3a. Upstage was observed in 3.6% of patients with cT1a and 19% with cT1b. The median preoperative diameter was 43 mm in the upstaged tumors. One local and five distant metastatic recurrences occurred during the median follow-up period of 59 months, with a median time to distant recurrence of 30 months. Fuhrman grade ≥3 was identified as a significant factor for distant metastatic recurrence. The metastasis-free survival, cancers pecific survival, and overall survival at five years postoperatively were 75. 7%, 96. 2%, and 88. 1%, respectively. Among the upstaged patients, those with higher Fuhrman grade should be carefully monitored for recurrence.
著作権等: 許諾条件により本文は2025-08-01に公開
DOI: 10.14989/ActaUrolJap_70_7_193
URI: http://hdl.handle.net/2433/290649
PubMed ID: 39592452
出現コレクション:Vol.70 No.7

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。